Editors' ChoiceCancer

Special delivery by “armored” CAR-T

See allHide authors and affiliations

Science Translational Medicine  05 Sep 2018:
Vol. 10, Issue 457, eaav0334
DOI: 10.1126/scitranslmed.aav0334


The integration of immune checkpoint blockade with CAR-T cell therapy improves antitumor efficacy with potential for reduced side effects.

View Full Text

Stay Connected to Science Translational Medicine